BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
Completed · Not applicable
Conditions studied: Sinus Node Dysfunction, Bradycardia, Atrioventricular Block
In brief
The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia CSP S pacing lead when implanted in the left bundle branch area (LBBA). Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post-implant. Efficacy will be assessed by evaluating implant success rate.
Key facts
- Study ID
- NCT06540079
- Run by
- Biotronik, Inc.
- People needed
- 192
- Starts
- 2024-12-18
- Expected to finish
- 2026-06-17
- Last updated by the study team
- 2026-07-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient is a candidate for implantation of a BIOTRONIK pacemaker system, per standard guidelines. Single chamber, dual chamber, and CRT-P systems are allowed.
- Patient has an implant planned to utilize left bundle branch area (LBBA) pacing within 30 days of consent
- Patient is able to understand the nature of the study and provide written informed consent
- Patient is available for follow-up visits on a regular basis for the expected duration of follow-up
- Patient accepts Home Monitoring® concept
- Patient age is greater than or equal to 18 years at time of consent
You may not qualify if…
- Patient meets a standard contraindication for pacemaker system implant
- Patient is currently implanted with a pacemaker or ICD device
- Patient has had a previous unsuccessful attempt to place a lead in the LBBA
- Patient has planned cardiac surgical procedures or interventional measures within 3 months after implant
- Patient is expected to receive a heart transplant within 12 months
- Patient life expectancy less than 12 months
- Patient has the presence of another life-threatening, underlying illness separate from their cardiac disorder
- Patient reports pregnancy at the time of enrollment
- Patient is enrolled in any other investigational cardiac clinical study during the course of the study
Where it is running
- Banner - University Medical Center Phoenix — Phoenix, Arizona, United States
- Cardiology Associates Medical Group — Ventura, California, United States
- Sarasota Memorial Hospital — Sarasota, Florida, United States
- University of Chicago — Chicago, Illinois, United States
- Cardiology Associates Research, LLC — Tupelo, Mississippi, United States
- NYU Heart Rhythm Center — New York, New York, United States
- Weill Cornell Medicine — New York, New York, United States
- Atrium Health Wake Forest Baptist Medical Center — Winston-Salem, North Carolina, United States
- Cardiology Consultants of Philadelphia — Paoli, Pennsylvania, United States
- Geisinger Wyoming Valley Medical Center — Wilkes-Barre, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.